COMMUNIQUÉS West-GlobeNewswire

Immunomedics to Present at the 36th Annual J.P. Morgan Healthcare Conference

04/01/2018 - 14:45

MORRIS PLAINS, N.J., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU ) (“Immunomedics” or the “Company”) today announced that Michael Pehl, President and Chief Executive Officer, will present an [...]

Ultragenyx to Present at J.P. Morgan Healthcare Conference

04/01/2018 - 14:35

NOVATO, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]

Auris Medical Provides Update on AM-111 Development Program

04/01/2018 - 14:30

Further analyses from HEALOS Phase 3 clinical trial support AM-111's otoprotective effects in patients with profound acute hearing loss Clinically and statistically significant improvement in hearing coupled with [...]

Cascadian Therapeutics Announces 2018 Outlook and Recent Progress

04/01/2018 - 14:30

SEATTLE, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ: CASC ), a clinical-stage biopharmaceutical company, today announced an overview of recent progress for tucatinib, an investigational oral [...]

International Endeavors Excited About California Marijuana Legalization

04/01/2018 - 14:30

TEMECULA, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE — International Endeavors Corp (OTC:IDVV) is pleased to announce the following: The arrival of 2018 in California brought with it broad legalization of [...]

EyeGate Promotes Sarah Romano to Chief Financial Officer

04/01/2018 - 14:30

WALTHAM, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), a clinical-stage, specialty pharmaceutical company with two platform technologies for [...]

American Cannabis Company, Inc. Announces It Has Secured A Contract With A New Client In California

04/01/2018 - 14:30

DENVER, CO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC”), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis [...]

PTS Diagnostics Announces New Retail Point-of-Care Software

04/01/2018 - 14:15

PTS Connect ProLink ® platform expands connectivity and informatics offerings INDIANAPOLIS, Jan. 04, 2018 (GLOBE NEWSWIRE) -- PTS Diagnostics, a U.S.-based manufacturer of point-of-care biometric testing devices, today [...]

Cognition Therapeutics Co-Founder and CSO Susan Catalano to Present at Sachs Neuroscience Innovation Forum

04/01/2018 - 14:05

Pittsburgh, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of Alzheimer’s disease and other [...]

GTX Corp and Veristride Presenting Biometric Insoles at CES 2018

04/01/2018 - 14:02

LOS ANGELES, Jan. 04, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO ), an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive technology business, announced today that [...]

Allscripts to release fourth-quarter and full-year 2017 financial results February 15

04/01/2018 - 14:01

CHICAGO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc . (Nasdaq: MDRX ) will report its financial results for the three months and full year ended December 31, 2017, after the close of stock [...]

Catalyst Biosciences Initiates Phase 2/3 Trial of Marzeptacog Alfa (activated) for Prophylaxis in Hemophilia A or B with Inhibitors

04/01/2018 - 14:00

Currently Enrolling Individuals with Hemophilia A or B with Inhibitors Interim Data Expected During the First Half of 2018 SOUTH SAN FRANCISCO, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. ( [...]

Foamix Announces Positive Results from Phase 3 Open-Label Safety Extension Evaluating FMX-101 Topical Minocycline Foam for Treatment up to 1 Year

04/01/2018 - 14:00

Long Term Data on FMX-101 in Moderate-to-Severe Acne to be Presented at Winter Clinical Dermatology Conference (January 12 th -17 th ) REHOVOT, Israel and BRIDGEWATER, N.J., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Foamix [...]

Celtaxsys Secures Private Financing to Advance Acebilustat Phase 3 Cystic Fibrosis (CF) Program Preparatory Activities

04/01/2018 - 14:00

ATLANTA, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for rare inflammatory diseases, today announced the successful completion of a [...]

aTyr Pharma to Present at the 36th Annual J.P. Morgan Healthcare Conference

04/01/2018 - 14:00

SAN DIEGO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]

Cellectar Biosciences to Participate at Biotech Showcase 2018

04/01/2018 - 14:00

MADISON, Wis., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the [...]

Tyme Announces Presentation of Clinical Data on SM-88 in Prostate Cancer at 2018 ASCO Genitourinary Cancers Symposium

04/01/2018 - 14:00

Mack Roach, M.D., FASCO , University of California, San Francisco, to present data from ongoing Phase II clinical trial NEW YORK, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (Nasdaq: TYME ), a clinical- [...]

HTG Announces Preliminary Fourth Quarter and Full Year 2017 Unaudited Financial Results and Provides Initial 2018 Revenue Guidance

04/01/2018 - 14:00

Fourth quarter 2017 revenue expected to be between $6.9 and $7.2 million Full year 2017 revenue expected to be between $13.8 and $14.1 million Initial full year 2018 revenue guidance of $20.0 to $25.0 million TUCSON, [...]

Rhythm Pharmaceuticals Announces Progress in Clinical Development of Setmelanotide for Treatment of Rare Genetic Disorders of Obesity

04/01/2018 - 14:00

- Final protocol confirmed for pivotal Phase 3 clinical trial in pro-opiomelanocortin (POMC) deficiency obesity - - Setmelanotide granted Orphan Drug Designation for treatment of leptin receptor (LEPR) deficiency [...]